These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12183250)

  • 21. Inhibition of herpes simplex virus type 1 and type 2 infections by peptide-derivatized dendrimers.
    Luganini A; Nicoletto SF; Pizzuto L; Pirri G; Giuliani A; Landolfo S; Gribaudo G
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3231-9. PubMed ID: 21576438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Digallate dimers of (-)-epigallocatechin gallate inactivate herpes simplex virus.
    Isaacs CE; Xu W; Merz G; Hillier S; Rohan L; Wen GY
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5646-53. PubMed ID: 21947401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.
    Schuhmacher A; Reichling J; Schnitzler P
    Phytomedicine; 2003; 10(6-7):504-10. PubMed ID: 13678235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry.
    Herold BC; Gerber SI; Belval BJ; Siston AM; Shulman N
    J Virol; 1996 Jun; 70(6):3461-9. PubMed ID: 8648678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro inactivation of herpes simplex virus by a biological response modifier, PSK.
    Monma Y; Kawana T; Shimizu F
    Antiviral Res; 1997 Aug; 35(3):131-8. PubMed ID: 9298752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by Santolina insularis essential oil.
    De Logu A; Loy G; Pellerano ML; Bonsignore L; Schivo ML
    Antiviral Res; 2000 Dec; 48(3):177-85. PubMed ID: 11164504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of sodium polyanethol sulfonate on herpes simplex virus-1 infection in vitro.
    Li J; Cheng C; Lin T; Xue R; Liu X; Wu K
    Mol Vis; 2022; 28():516-525. PubMed ID: 37089702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and characterization of an anti-HSV polysaccharide from Prunella vulgaris.
    Xu HX; Lee SH; Lee SF; White RL; Blay J
    Antiviral Res; 1999 Nov; 44(1):43-54. PubMed ID: 10588332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenoxazine derivatives suppress the infections caused by herpes simplex virus type-1 and herpes simplex virus type-2 intravaginally inoculated into mice.
    Hayashi K; Hayashi T; Miyazawa K; Tomoda A
    J Pharmacol Sci; 2010; 114(1):85-91. PubMed ID: 20736512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Chono K; Katsumata K; Suzuki H; Shiraki K
    Antiviral Res; 2013 Feb; 97(2):154-60. PubMed ID: 23261844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate.
    Krebs FC; Miller SR; Malamud D; Howett MK; Wigdahl B
    Antiviral Res; 1999 Oct; 43(3):157-73. PubMed ID: 10551374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus.
    Schnitzler P; Schneider S; Stintzing FC; Carle R; Reichling J
    Phytomedicine; 2008 Dec; 15(12):1108-16. PubMed ID: 18691858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacies of gel formulations containing foscarnet, alone or combined with sodium lauryl sulfate, against establishment and reactivation of latent herpes simplex virus type 1.
    Piret J; Lamontagne J; Désormeaux A; Bergeron MG
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1030-6. PubMed ID: 11257012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus.
    Du R; Wang L; Xu H; Wang Z; Zhang T; Wang M; Ning Y; Deng F; Hu Z; Wang H; Li Y
    Antiviral Res; 2017 Nov; 147():131-141. PubMed ID: 29061442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-HSV-2 activity of Terminalia chebula Retz extract and its constituents, chebulagic and chebulinic acids.
    Kesharwani A; Polachira SK; Nair R; Agarwal A; Mishra NN; Gupta SK
    BMC Complement Altern Med; 2017 Feb; 17(1):110. PubMed ID: 28196487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The synergistic effects of betulin with acyclovir against herpes simplex viruses.
    Gong Y; Raj KM; Luscombe CA; Gadawski I; Tam T; Chu J; Gibson D; Carlson R; Sacks SL
    Antiviral Res; 2004 Nov; 64(2):127-30. PubMed ID: 15498608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Herpes simplex virus type 1 glycoprotein K is not essential for infectious virus production in actively replicating cells but is required for efficient envelopment and translocation of infectious virions from the cytoplasm to the extracellular space.
    Jayachandra S; Baghian A; Kousoulas KG
    J Virol; 1997 Jul; 71(7):5012-24. PubMed ID: 9188566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of a N,N'-bisheteryl derivative of dispirotripiperazine to heparan sulfate residues on the cell surface specifically prevents infection of viruses from different families.
    Schmidtke M; Karger A; Meerbach A; Egerer R; Stelzner A; Makarov V
    Virology; 2003 Jun; 311(1):134-43. PubMed ID: 12832211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zinc Sulfate in Narrow Range as an In Vitro Anti-HSV-1 Assay.
    Fani M; Khodadad N; Ebrahimi S; Nahidsamiei R; Makvandi M; Teimoori A; Langari H
    Biol Trace Elem Res; 2020 Feb; 193(2):410-413. PubMed ID: 31028520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
    Bourinbaiar AS; Coleman CF
    Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.